Singulair Sales Data
Last updated: May 2013 (updated quarterly).
The following data shows Singulair U.S. retail sales in Q1 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q3 2012 | 23 ( 20) |
$486,837 | -62.20% | 2,657 | -62.80% |
| Q2 2012 | 3 ( 1) |
$1,287,806 | 4.01% | 7,142 | 3.72% |
| Q1 2012 | 4 (1) |
$1,238,134 | 8.67% | 6,886 | -0.03% |
| Q4 2011 | 5 | $1,139,301 | 2.59% | 6,888 | 3.30% |
| Q3 2011 | 5 | $1,110,538 | -4.34% | 6,668 | -10.40% |
| Q2 2011 | 5 (3) |
$1,160,959 | 11.74% | 7,442 | 6.34% |
| Q1 2011 | 8 | $1,038,949 |  |
6,998 | |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
See Also
Related News
| Date | Article |
|---|---|
| December 5, 2011 | More Children Using Preventive Asthma Drugs: Study |
| June 13, 2011 | FDA Approves Redesigned Labels for Some Merck Drugs |
| March 16, 2009 | New Treatments Improve Control for Severe Asthma |
| January 14, 2009 | FDA Finds No Link So Far Between Asthma Drugs and Suicide Risk |
| January 14, 2009 | Merck Statement in Response to the FDA's Update Regarding a Safety Review of Singulair (montelukast) |
| November 24, 2008 | Study Calls for Greater Scrutiny of 'Off-Label' Drug Use |
